Gilead Sciences, Inc.GILDNASDAQ
Loading
Interest Expense Over TimeStable
Percentile Rank86
3Y CAGR+3.1%
5Y CAGR+0.8%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+3.1%/yr
vs -3.5%/yr prior
5Y CAGR
+0.8%/yr
Consistent
Acceleration
+6.6pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.02B | +4.8% |
| 2024 | $977.00M | +3.5% |
| 2023 | $944.00M | +1.0% |
| 2022 | $935.00M | -6.6% |
| 2021 | $1.00B | +1.7% |
| 2020 | $984.00M | -1.1% |
| 2019 | $995.00M | -7.6% |
| 2018 | $1.08B | -3.7% |
| 2017 | $1.12B | +16.0% |
| 2016 | $964.00M | - |